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Abstract
Background: 
This study investigated symptom patterns that might distinguish between individuals with 
and without a diagnosis of Social Phobia (SP) across the adult lifespan.  
Methods: 
A sample of 5,411 self-reported social worriers was derived from Wave 1 (2001-2002) of the 
U.S. National Epidemiological Survey of Alcohol and Related Conditions (NESARC). 
Participants were stratified into four age groups (18-29 years, 30-44 years, 45-64 years, 65-96 
years), and further divided into two diagnostic groups (self-reported social worriers with and 
without a SP diagnosis).  
Results: 
Binary logistic regression analyses revealed that a core set of symptoms was associated with 
SP across the adult lifespan. There were also successive reductions in the number of 
symptoms associated with SP in each age group, such that older adults endorsed numerically 
fewer SP symptoms. 
Limitations: 
Though our sample size is smaller than ideal for the nature of our analyses, the NESARC 
represents one of the largest existing clinical datasets we know of. 
Conclusions: 
Despite age-related reductions in symptom frequency, a core set of SP symptoms consistently 
distinguished between diagnostic groups, irrespective of age.  
Keywords: social anxiety; symptom presentation; assessment; diagnosis 
1. Introduction 
Social Phobia (SP), also known as Social Anxiety Disorder, is characterised by 
apprehension toward social or interpersonal situations, which the afflicted individual actively 
avoids or endures with extreme discomfort due to a pervasive fear of criticism, rejection, 
and/or humiliation (APA , 1994; WHO, 2010). In order to constitute a diagnosis, these 
symptoms must be considered by the individual to be distressing and/or disabling in everyday 
situations (APA, 1994). In recent epidemiological studies, the lifetime prevalence of SP has 
been estimated to range from 5% to 12.1%, and the 12-month prevalence has been estimated 
to range from 2.8% to 7.1% (Grant et al. 2005; Kessler et al. 2005; Ruscio et al. 2008). SP is 
associated with poor quality of life and increased number of missed days at work (Alonso et 
al. 2004; Stein & Kean, 2000). SP is also a risk factor for major depression and substance 
abuse disorders, and is often comorbid with these disorders (Lampe et al., 2003; Stein & 
Stein, 2008). Several studies have found that pure SP is associated with increased suicidal 
ideation and suicidal behaviours, and that psychiatric comorbidities strengthen this link 
(Sareen et al. 2002; Schneier et al., 1992; Thibodeau et al. 2013).  
Age-related changes in the prevalence of anxiety disorders and presentation of anxiety 
symptoms complicate diagnosis and treatment of anxiety disorders, with such complications 
particularly manifest in older adults (Flint, 2007; Stanley et al., 1996; Gonçalves & Byrne, 
2013; Wolitzky-Taylor et al., 2010). Lifetime and 12-month prevalence estimates of SP 
among older adults are reported to range from 3.5% to 6.6% and 1.3% to 2.3%, respectively – 
about half the prevalence estimates found in younger cohorts (Cairney et al. 2007; Chou, 
2009; Gum et al., 2009; Kessler et al, 2005). Despite these age-related reductions in 
prevalence estimates, anxiety disorders remain among the most highly prevalent mental 
health disorders in older adults.  
Despite some overlap in SP symptom patterns endorsed by younger and older adults, 
there are also some notable phenomenological differences between these age groups. Older 
adults have been found to endorse overall fewer and distinctive types of SP symptoms 
relative to younger adults on the Social Phobia and Anxiety Inventory (SPAI) (Gretarsdottir 
et al., 2004). Whereas younger adults (aged 17 – 55) scored significantly higher than older 
adults (aged 60 – 94) on 19 of 32 symptoms, older adults scored higher on only 2 of 32 
symptoms, with no significant differences between age groups on the remaining 11 
symptoms. The specific symptoms on which older adults endorsed greater severity were: 
“anxious when talking about business” and “anxious when writing or typing in front of 
others.” Similar trends have also been observed in studies assessing age-related differences in 
the phenomenology of Generalized Anxiety Disorder, Post-Traumatic Stress Disorder, and 
Specific Phobia, such that these disorders are associated with age-related reductions in the 
number of reported symptoms, and differences in the phenomenology of symptoms (Bottche 
et al., 2012; Deer & Calamari, 1998; Frueh et al. 2004; Gonçalves & Byrne, 2013; Gould & 
Edelstein, 2010; Miloyan et al., 2014).  
The purpose of the current study was to determine the nature of symptoms that 
distinguish between individuals with a diagnosis of SP and individuals with sub-threshold SP 
symptoms across the adult lifespan. Sub-threshold SP is typically characterized by symptoms 
not meeting diagnostic threshold, and previous research has found that sub-threshold SP 
bears some clinical significance (Stein et al., 2000). We hypothesized that a distinctive 
pattern of symptoms would distinguish between socially anxious adults with and without a 
diagnosis of SP in different age groups. Based on previous findings, we also expected to 
observe an age-related decrease in the number of SP symptoms endorsed, with older adults 
endorsing fewer symptoms. 
2. Method 
2.1 Sample 
The National Epidemiological Survey of Alcohol and Related Conditions (NESARC) 
was undertaken in 2001-2002 in a nationally representative sample of 43,093 civilian, non-
institutionalized adults who were sampled from all 50 U.S. states and the District of 
Columbia. The overall response rate was 81%. African-Americans, Hispanics, and young 
adults were purposively oversampled, and sampling weights were used to adjust data for 
oversampling and nonresponse, and to allow population estimates to be standardized against 
census data. 
Only participants who endorsed one of three screening questions (“Ever had strong 
fear or avoidance of social situation?”, “Had fear/avoidance of social situation due to fear of 
embarrassment at what you might say/do around others?” or “Had fear/avoidance of social 
situation due to fear of becoming speechless, having nothing to say or saying something 
foolish?”) were included in the current analyses because these were the only individuals who 
were further assessed for SP symptoms (N=5,411). SP symptoms included participant 
responses (Yes or No) to 26 questions from the SP section of the AUDADIS-IV diagnostic 
interview, which addressed DSM-IV Social Phobia symptom clusters. For a full list of the 
symptoms that were assessed, see the Supplementary Data File. 
2.2 Measures 
Twelve-month non-hierarchical SP diagnoses were obtained by trained interviewers 
using the Alcohol Use Disorder and Associated Disabilities Interview Schedule – DSM-IV 
version (AUDADIS-IV). All analyses accounted for gender, education (some college or 
higher, completed high school, less than high school), personal income ($0-9,999; $10,000-
34,999; $35,000+), marital status (married/cohabiting, widowed/divorced/separated, never 
married), urbanicity (urban, rural), geographic region (Northeast, Midwest, South, West), 
self-perceived health (excellent, very good, good, fair, poor), and chronic medical conditions 
(none, one or more).  
2.3 Procedure 
 Participants were stratified into one of four age groups (18-29yrs; 30-44yrs; 45-64yrs; 
65-96yrs) and one of two diagnostic groups (12-month SP diagnosis; or Sub-Threshold SP). 
Four sets of binary logistic regression analyses were performed to determine the symptoms 
that best distinguished between individuals with threshold and sub-threshold SP within each 
age group.  
2.4 Statistical Analyses 
Stata 12.0 was used to conduct all statistical analyses, and survey commands were 
used to account for the complex survey design of the NESARC (Statacorp, 2011). Raw 
frequencies, weighted proportions, and chi-square tests were calculated within age groups 
and between diagnostic groups. Preliminary analyses assessing the proportion of each 
symptom between individuals with sub-threshold and threshold SP justified the inclusion of 
all symptoms assessed in the diagnostic interview.  Weighted binary logistic regression 
analyses using Odds Ratios (ORs) indicated the specific symptoms that best distinguished 
between individuals with and without an SP diagnosis in each age group, after accounting for 
sociodemographic and health variables.  
3. Results 
3.1 Socio-demographic characteristics of the sample 
The overall sample comprised 5,411 individuals reporting social worries. These 
individuals represented 12.6% of the total survey population. The 18-29 year old subgroup 
consisted of 1,158 participants (Mage= 23, 55% female), the 30-44 year old subgroup 
consisted of 1,666 participants (Mage= 37, 58% female), the 45-64 year old subgroup 
consisted of 1,740 participants (Mage= 53, 60% female), and the 65-96 subgroup consisted of 
847 participants (Mage= 75, 68% female).  
Within the sample used for these analyses, 1,159 participants (21.4%) had a 12-month 
SP diagnosis. Seventy-seven percent of the sample reported that their health was good, very 
good, or excellent, and fifty-six percent reported an absence of chronic medical conditions. 
Eighty-two percent of the sample had completed a high school education, and fifty percent 
had completed at least some college. Approximately a third of the sample reported an annual 
personal income greater than $35,000. Forty-seven percent of participants were either 
married or cohabiting, twenty-seven percent were either widowed, divorced, or separated, 
and twenty-six percent were never married.  
3.2 Number of Symptoms 
Figure 1 illustrates the trend of SP symptom count with increasing age, indicating a 
slight linear decline in the number of SP symptoms endorsed by increasingly older 
individuals. Though the term decline is typically reserved for longitudinal data, we use it here 
to highlight cross-sectional decreases in symptom frequency by increasing age. 
3.3 Type of Symptoms 
Binary logistic regression analyses revealed that a core set of six distinct symptoms 
was associated with SP across the adult lifespan, irrespective of age. The symptoms “thinking 
about social situations almost always made you anxious”, “usually became upset / anxious 
when had to be in social situations”, “remained in social situations because had to be there, 
even though it made you anxious”, “avoid social situations because of strong fear of them”, 
“thought you were more anxious about social situations than most people, and “thought own 
fear/avoidance of these social situations was stronger than should be” were significant 
individual predictors of SP group membership across the adult lifespan.  In other words, these 
six symptoms of SP were age invariant. In addition to these six core symptoms that were 
significantly associated with a SP diagnosis in each age group, a relatively distinctive set of 
additional symptoms distinguished between individuals with and without a SP diagnosis in 
each age group (See Table 2).  
 In terms of sociodemographic, health, and comorbidity variables, only one variable 
(12-month diagnosis of anxiety disorder [not including SP]) was an age invariant predictor of 
a current SP diagnosis. Aside from this, different sets of sociodemographic, health and 
comorbidity variables were associated with SP in each age group. 
4. Discussion 
The results of this study suggest that a core set of symptoms is associated with SP 
across the adult lifespan, and that there is a progressive age-related reduction in the number 
of symptoms associated with SP. These results are particularly noteworthy because they 
indicate that a core set of symptoms is capable of distinguishing between adults with and 
without an SP diagnosis, irrespective of age. Moreover, the utility of these symptoms for 
distinguishing between individuals with threshold and sub-threshold SP seems to persist in 
spite of the decreasing number of symptoms endorsed in progressively older age groups.
Finally, by demonstrating that fewer symptoms are associated with SP diagnosis in older 
adults, these results account for some of the difficulty associated with diagnosing late-life 
anxiety, and underscore a need for more careful assessment of SP symptoms in older adults.  
Our findings are also consistent with those of a previous study, which reported that 
the general profile of SP is largely stable across adulthood, despite age-related reductions in 
SP symptoms (Gretarsdottir et al., 2004). In fact, the finding of age-related decreases in SP 
severity is also consistent with a large body of research indicating that fewer symptoms are 
associated with late-life Generalised Anxiety Disorder, Post-Traumatic Stress Disorder, and 
Panic Disorder (Bottche et al., 2012; Deer & Calamari, 1998; Frueh et al. 2004; Gonçalves & 
Byrne, 2013; Gould & Edelstein, 2010; Miloyan et al., 2014). It is likely that age-related 
reductions in the number of symptoms associated with SP, and with anxiety symptoms in 
general, contribute to difficulties in the detection of late-life anxiety disorders. An important 
direction for future research is to determine the nature of age-related reductions in the number 
and severity of anxiety symptoms. Furthermore, it will be important to determine whether 
older adulthood is associated with a lower threshold of anxiety symptoms required to account 
for disability and distress. If fewer symptoms account for clinically significant disability and 
distress in old age, this would have key implications for prevalence estimates, and for the 
detection and management of anxiety disorders.  
The utility of an age invariant set of symptoms for identifying SP could be useful in 
guiding the development of screening questionnaires. Given the highly comorbid nature of 
SP, a screening tool might also confer a benefit for identifying individuals with 
psychopathology in a variety of contexts.  In fact, a concurrent 12-month diagnosis of anxiety 
disorder (not including SP) was also an age invariant predictor of SP diagnosis in this sample, 
suggesting an indirect association between this core set of symptoms and anxiety disorders in 
general. It must be noted that there were also important differences between cohorts, such 
that some variables were uniquely associated with clinical SP in a particular cohort. For 
example, personality disorders were selectively and positively associated with SP in younger 
adults (aged 18 – 44), whereas a lifetime diagnosis of anxiety was uniquely and negatively 
associated with SP in middle-aged and older adults (aged 45 – 96). Furthermore, a concurrent 
12-month diagnosis of mood disorder was uniquely and positively associated with SP in the 
18 – 29 year old cohort. 
Due to the design of the NESARC, only individuals who provided an affirmative 
response to one of three screening questions about social anxiety were further probed for SP 
symptoms, and were subsequently included in our analyses. Due to this design feature, an 
asymptomatic comparison group was effectively excluded from further examination. While 
the absence of an asymptomatic control group for comparative purposes may be considered a 
weakness of our methodology, we contend that this does not represent a major limitation of 
our study. Clinical diagnosis frequently involves distinguishing between individuals with 
pathological SP compared to those with non-pathological SP (i.e. those with sub-threshold 
symptoms) whilst clinical decisions involving asymptomatic individuals are generally 
straightforward. Although we acknowledge that inclusion of an asymptomatic group would 
have been informative, we believe the absence of such a group does not significantly detract 
from the clinical value of these findings. 
However, there are some important limitations to our study. First, all SP symptoms 
were pre-selected and assessed with dichotomous responses (‘Yes’ or ‘No’). Therefore, 
differences in the severity of each individual symptom reported could not be investigated. 
Further, participant responses could not be followed up with more specific questions 
regarding the nature of SP symptoms, and a more detailed analysis of changes in SP 
phenomenology across the adulthood was not possible. 
Second, psychiatric comorbidity was accounted for such that anxiety, mood, and 
personality disorders were clustered together into general categories. It therefore remains 
unclear whether specific comorbidities feature more or less prominently with SP, and 
whether these might impact the presentation of SP symptoms in different age groups. It also 
remains unclear whether age-related decreases in SP symptoms occur over and above those 
of age-related reductions in other types of anxiety. Future studies should provide a more 
detailed assessment of the relationship between SP diagnosis, symptom patterns, and 
psychiatric comorbidity across adulthood. Finally, though our sample size is smaller than 
ideal for such analyses, the NESARC dataset remains among the largest recent datasets we 
know of that was specifically designed for addressing such questions.  
5. Conclusion 
We have outlined the symptom patterns that distinguish between individuals with and 
without a diagnosis of SP, demonstrating the presence of a core set of symptoms associated 
with SP diagnosis across the adult lifespan, and a simultaneous reduction in the number of 
symptoms endorsed by older adults. On one hand, these findings suggest that SP presents 
consistently throughout adulthood. On the other hand, the findings suggest that diagnostic 
criteria might account for age-related reductions in SP symptoms. More research is needed to 
determine the nature of age-related differences in the number and phenomenology of anxiety 
symptoms.  
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Figure 1. Estimates of cross-sectional changes in Social Phobia symptom frequency. 
Table 1. Comparison of socio-demographic, health, and comorbidity characteristics, by 
current Social Phobia diagnosis.
raw frequencies (and weighted proportions) 
 Asymptomatic 
n = 37,682 
Sub-Threshold* 
n = 4,252 
Social Phobia 
n = 1,159 
Age 47 ± 18.27 46 ± 17.79 43 ± 16.00 
Sex
   Male 
   Female 
16,333 (48%) 
21,349 (52%) 
1,787 (47%) 
2,465 (53%) 
398 (37%) 
761 (63%) 
Education 
   Some college or higher 
   Completed high school 
   Less than high school 
19,975 (55%) 
10,821 (29%) 
6,886   (16%) 
2,155 (52%) 
1,360 (32%) 
737    (16%) 
226 (18%) 
366 (32%) 
567 (50%) 
Personal Income 
   35,000+ 
   10,000 – 34,999 
   0 – 9,999 
10,748 (31%) 
16,780 (43%) 
10,154 (26%) 
1,019 (25%) 
1,938 (44%) 
1,295 (31%) 
250 (23%) 
500 (43%) 
409 (34%) 
Marital Status 
   Married 
   Widowed/divorced/separated 
   Never married 
19,548 (62%) 
9,664   (17%) 
8,470   (21%) 
1,996 (57%) 
1,151 (19%) 
1,105 (24%) 
537 (58%) 
302 (18%) 
320 (24%) 
Urbanicity 
   Urban 
   Rural 
31,003 (81%) 
6,679   (19%) 
3,406 (78%) 
846    (22%) 
888 (74%) 
271 (26%) 
Self-Perceived Health 
   Excellent 
   Very Good 
   Good 
   Fair 
   Poor 
11,132 (32%) 
10,904 (30%) 
9,191   (24%) 
4,347   (10%) 
1,850   (4%) 
980    (23%) 
1,207 (31%) 
1,146 (27%) 
655    (14%) 
        256    (5%) 
204 (19%) 
313 (29%) 
312 (26%) 
217 (17%) 
113 (9%) 
Chronic Medical 
   None 
   One or more 
25,055 (68%) 
12,627 (32%) 
2,443 (60%) 
1,809 (40%) 
613 (54%) 
546 (46%) 
Current Anxiety 
   No 
   Yes 
34,730 (92%) 
2,952   (8%) 
3,483 (83%) 
769    (17%) 
569 (50%) 
590 (50%) 
Current Mood 
   No 
   Yes 
34,556 (92%) 
3,116   (8%) 
3,399 (81%) 
853    (19%) 
673 (58%) 
486 (42%) 
Lifetime Anxiety 
   No 
   Yes 
33,059 (88%) 
4,623   (12%) 
2,964 (70%) 
1,288 (30%) 
442 (38%) 
717 (62%) 
Lifetime Mood 
   No 
   Yes 
31,013 (82%) 
6,669   (18%) 
2,554 (61%) 
1,698 (39%) 
425 (37%) 
734 (63%) 
Lifetime Personality 
   No 
   Yes 
33,341 (88%) 
4,341   (12%) 
2,700 (63%) 
1,552 (37%) 
446 (38%) 
713 (62%) 
*‘Sub-threshold’ includes all participants who endorsed at least one of three screening questions without a 
diagnosis of SP 
Table 5. Summary of binary logistic regression analyses showing symptoms distinguishing 
between worriers with and without Social Phobia by age group. 
ODDS RATIOS and 95% CIs
18 – 29 years old 30 – 44 years old 45 – 64 years old 65 – 96 years old
CORE SET OF SYMPTOMS: 
Usually became upset / 
anxious when had to be in 
SS? 
11.91  6.07 – 23.37***
Usually became upset / 
anxious when had to be in 
SS? 
8.81   4.82 – 16.08***
Usually became upset / 
anxious when had to be in 
SS? 
4.48    2.60 – 7.72***
Usually became upset / 
anxious when had to be 
in SS? 
6.82   2.49 – 18.70***
Thought own fear / 
avoidance of SS stronger 
than should be? 
3.49     2.11 – 5.75***
Thought own fear / 
avoidance of SS stronger 
than should be? 
5.93   3.73 – 9.41***
Thought own fear / 
avoidance of SS stronger 
than should be? 
10.15    6.14 – 16.76***
Thought own fear / 
avoidance of SS 
stronger than should be?
7.95   3.69 – 17.15***
Avoid SS because of 
strong fear? 
2.40     1.53 – 3.75***
Avoid SS because of 
strong fear? 
1.85   1.27 – 2.70**
Avoid SS because of 
strong fear? 
2.14    1.49 – 3.07***
Avoid SS because of 
strong fear? 
2.96   1.60 – 5.47**
Thinking about SS almost 
always made you 
anxious? 
1.88      1.22 – 2.92** 
Thinking about SS almost 
always made you 
anxious? 
2.06   1.43 – 2.96*** 
Thinking about SS almost 
always made you 
anxious? 
2.50   1.71 – 3.65*** 
Thinking about SS 
almost always made you 
anxious? 
2.61   1.25 – 5.46* 
Remained in SS because 
had to, even though very 
anxious? 
2.13     1.10 – 4.13* 
Remained in SS because 
had to, even though very 
anxious? 
2.01   1.18 – 3.42* 
Remained in SS because 
had to, even though very 
anxious? 
2.18   1.35 – 3.51** 
Remained in SS because 
had to, even though 
very anxious? 
3.60   1.70 – 7.67** 
Thought you were more 
anxious about SS than 
most people 
6.89     3.98 – 11.93***
Thought you were more 
anxious about SS than 
most people 
2.43   1.62 – 3.64*** 
Thought you were more 
anxious about SS than 
most people 
1.97   1.33 – 2.92** 
Thought you were more 
anxious about SS than 
most people 
2.18   1.14 – 4.17* 
ADDITIONAL SYMPTOMS: 
(1) Fear/avoidance of 
eating or drinking in 
public? 
.54   .30 – .98*
(1) Remained in SS 
because had to, even 
though anxious of having 
panic attack? 
.38   .20 – .73**
(1) Fear/avoidance of 
being in small group 
situation? 
.58   .36 – .94*
(1) Fear / avoidance of 
performing in front of 
others? 
.32   .14 – .73**
(2) Often needed to bring 
someone along to SS in 
case of panic attack? 
3.47   1.07 – 11.27*
(2) Avoided SS because 
of fear of having panic 
attack? 
4.79   2.15 – 10.69***
(2) In SS that made you 
anxious, ever have a panic 
attack? 
2.52   1.22 – 5.22*
(3) Fear/avoidance of 
writing while someone 
else watches? 
1.89   1.11 – 3.21*
(3) Fear/avoidance of 
talking in front of others? 
2.00   1.13 – 3.56*
(3) Fear/avoidance of 
taking part or speaking in 
a meeting? 
1.64   1.06 – 2.54*
(4) Fear/avoidance of 
important exam? 
1.71   1.08 – 2.71*
 (4) Fear/avoidance of 
dating? 
1.57   1.05 – 2.36*
 (5) Fear/avoidance of any 
other SS?  
1.48   1.04 – 2.08*
SOCIODEMOGRAPHIC, HEALTH, AND COMORBIDITY VARIABLES: 
(1) 1-year anxiety 
disorder (no SP) 
2.26   1.13 – 4.51* 
(1) 1-year anxiety 
disorder (no SP) 
2.61   1.62 – 4.21*** 
(1) 1-year anxiety 
disorder (no SP) 
3.03   1.87 – 4.88*** 
(1) 1-year anxiety 
disorder (no SP) 
9.93   3.43 – 28.72*** 
(2) Personality disorder 
1.70   1.07 – 2.68* 
(2) Personality disorder 
1.46   1.03 – 2.06* 
(2) Lifetime anxiety 
disorder 
.45     .27 – .74** 
(2) Lifetime anxiety 
disorder 
.16     .06 – .46** 
(3) 1-year mood disorder 
2.68   1.44 – 5.00* 
  (3) Geographic region: 
West 
2.74   1.08 – 6.98* 
(4) Lifetime mood 
disorder 
.42    .22 – .80** 
   
(5) Self-perceived health: 
Fair
.42   .18 – .98* 
   
*p<.05; **p<.01; ***p<.0001; SS = Social Situations 
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